Patent · US Active

Peptide oligonucleotide conjugates

US9161948B2 · kind B2 · utility

35Cited by
36References
81Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 17, 2011
Grant dateOct 20, 2015
Priority date—
Expiry dateNov 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Oligonucleotide analogues conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.